// App-Quantinova.ai

EXTH-90 : HDAC INHIBITOR, CAY10603, IS A POTENT RADIOSENSITIZER IN MENINGIOMAS

Researchers

Presenter

  • Clemens Oliver Hanemann

Principal Investigators

  • Juri Na

Medical Centers

  • Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Meningiomas

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved